Reporting Data Item

Business Justification

Definition

Note: Where ‘NHS Wales Data Dictionary’ the definition is as per the Data Dictionary.

Permissible Values

8. DRUG THERAPY [including chemotherapy, hormone and biological agents]

8.0

ENCDv4.5b (9.10)

GCI

Date treatment started (drug therapy)

To determine the time interval between referral and diagnosis by the specialist team and the start of treatment. Required to be able to the measure survival time from the start of treatment. To enable the date of first definitive treatment to be recorded.

The date on which the drug therapy was first administered.

8.1

ENCDv4.5b (9.8)

GCI

Treatment intent (drug therapy)

To establish the frequency of different treatment intents.

To monitor treatment related outcomes. To assess patterns of chemotherapy or other drug therapy practice for comparison with best practice guidelines.

The intended outcome of the drug therapy to be administered.

Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.

•     Adjuvant

•     Neoadjuvant

•     Radical (curative)

•     Palliative

8.2

ENCDv4.5b (9.7)

Drug therapy type

To establish patterns of drug therapy treatment.

The type of drug therapy administered.

Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.

•     Chemotherapy

•     Hormone / endocrine therapy

•     Immunotherapy

•     Bisphosphonate therapy

•     Other

8.3

GCI

Treatment end date (drug therapy)

To determine the time interval between the start and end of drug therapy treatment. Required for the reporting of the gynaecological clinical indicators.

The date the last cycle of drug therapy was administered.